Map Chem

Mumbai, India Founded: 2012 • Age: 14 yrs
Wholesale supplier of pharmaceutical injections, tablets, and medicines in Mumbai.

About Map Chem

Map Chem is a Healthcare company based in Mumbai (India) founded in 2012 by Mithalal Sethia, Ankit Sethia, and Ashish Sethia. Wholesale supplier of pharmaceutical injections, tablets, and medicines in Mumbai. It operates on a B2B model. Its chief executive, as recorded, is Ashish Sethia. Its Indian entity Map Chem Private Limited reported revenue of β‚Ή40.84 Cr. Map Chem offers products and services including CAVIM 2.5 g, Cepofic 1.5 mg, Albuzest Protine Powder, DULAFUN 100 MG, and Etacept 25 Mg. Its focus areas include Pharmaceuticals, Medicines, Wholesale Distribution and Speciality Drugs. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.

Company details

Map Chem Private Limited is a private limited company based in Mumbai, Maharashtra, India, specializing in wholesale distribution of pharmaceutical products. They supply items such as injections, tablets, anti-cancer medicines, and nutritional supplements to businesses. Operating as a trader and wholesaler, they focus on quality pharmaceutical distribution, including critical care and HIV aids medicines, while ensuring compliance with GST regulations.

  • Headquarters Mumbai, India
  • Founders Mithalal Sethia, Ankit Sethia, Ashish Sethia
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website mapchem.net
  • Legal Name Map Chem Private Limited
  • Date of Incorporation 27 Aug, 2004
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹40.84 Cr

    FY 2024 · +19% YoY

  • Net Profit
    ₹35.8 Lakh

    FY 2024 · 1% margin

  • EBITDA
    ₹1.60 Cr

    FY 2024 · 4% margin

Products & Services of Map Chem

Map Chem offers a comprehensive portfolio of products and services, including CAVIM 2.5 g, Cepofic 1.5 mg, Albuzest Protine Powder, DULAFUN 100 MG, and Etacept 25 Mg.

CAVIM 2.5 g
Pharmaceutical Injection

Injection used for medical treatment purposes.

Cepofic 1.5 mg
Pharmaceutical Injection

Injection for therapeutic applications.

Albuzest Protine Powder
Nutritional Supplement

Protein powder for health support.

DULAFUN 100 MG
Pharmaceutical Tablet

Tablet for medical use.

Etacept 25 Mg
Pharmaceutical Injection

Injection for specific treatments.

ERTAPURE 1 GM
Pharmaceutical Injection

Injection for healthcare needs.

Tafero EM Tablets
Anti-Cancer Tablet

Tablet for cancer-related treatments.

Tofajak Tablets 5mg
Pharmaceutical Tablet

Tablet for medical purposes.

Board of directors of Map Chem Private Limited (Map Chem)

Map Chem Private Limited is the primary company behind Map Chem. The board of Map Chem Private Limited currently have 2 directors; the longest-serving is Ashish Mithalal Sethia, appointed in 2004. 7 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ashish Mithalal Sethia
DIN 01428188
Director27 Aug 200422 yrs 2 moMap Chem Private Limited
Ankit Mithalal Sethia
DIN 05326729
Director01 Aug 201214 yrs 3 moMap Chem Private Limited

People of Map Chem

3 people are tracked at Map Chem (3 in leadership).

NameRoleGroup
ex-Co-FounderLeadership
Co-FounderLeadership
Co-Founder, CEOLeadership
Premium access

Complete people profiles for Map Chem

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Map Chem

Figures of Map Chem Private Limited, the primary company behind Map Chem, for FY 2024. Revenue was ₹40.84 Cr (+19% year on year). Net profit was ₹35.8 Lakh (1% margin). EBITDA was ₹1.60 Cr (4% margin). Revenue has grown at a compounded annual rate of +19% over three years and +15% over five years.

  • ₹40.84 CrRevenue · FY 2024 · +19% YoY
  • ₹35.8 LakhNet profit · 1% margin
  • ₹1.60 CrEBITDA · 4% margin
  • ₹5 LakhPaid-up capital
  • +19%Revenue CAGR, 3 years
  • +15%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Map Chem Private Limited are on its company page.

Premium access

Detailed financial statements for Map Chem

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Map Chem

Map Chem has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
keimed.com2000Hyderabad, India$16.62M588
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
sandor.co.in1995Hyderabad, India$8.98M161
Provider of medical equipment, devices, and drugs distribution services
Premium access

Detailed similar companies of Map Chem

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Map Chem

The website of Map Chem (mapchem.net) receives about 1.6K visits a month.

  • Monthly visits
    1.6K

    ▲ 17.3% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Map Chem

Map Chem was founded in 2012.

Map Chem is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Ashish Sethia is the CEO of Map Chem, as recorded in our data. They have also founded this company.

The primary company behind Map Chem, Map Chem Private Limited, reported revenue of β‚Ή40.84 Cr for FY 2024, up 19% year on year.

Map Chem Private Limited is a private limited company based in Mumbai, Maharashtra, India, specializing in wholesale distribution of pharmaceutical products. They supply items such as injections, tablets, anti-cancer medicines, and nutritional supplements to businesses. Operating as a trader and wholesaler, they focus on quality pharmaceutical distribution, including critical care and HIV aids medicines, while ensuring compliance with GST regulations.

Map Chem's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.

Map Chem offers CAVIM 2.5 g, Cepofic 1.5 mg, Albuzest Protine Powder, DULAFUN 100 MG, and 4 more products and services.

Map Chem operates through Map Chem Private Limited.

The legal entities of Map Chem currently have 2 directors, including Ashish Mithalal Sethia, Ankit Mithalal Sethia.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available